Infraglottic Devices Market: Rising Prevalence of Airway Disorder to Drive Market Growth to US$ 4,977.4 Million by 2033.

As per the latest market research by Business Market Insights (BMI), the research report "Infraglottic Devices Market Size and Forecast (2025–2033)" forecasts how the market is set to surge 56.31% by 2033. The global infraglottic devices market is driven by the increasing prevalence of severe respiratory failure and the rising need for advanced airway support in critical care and surgical settings. Growing demand for secure airway access during long-duration ventilation is accelerating adoption. Expanding use in intensive care units and emergency medicine, along with continuous advancements in tracheal tube design and cuff technology, are further supporting sustained market growth.

The report forecasts the market to expand from US$ 3,184.4 million in 2025 to US$ 4,977.4 million by 2033, registering a robust CAGR of 5.4% over the 2026–2033 period.

The global infraglottic devices market is a critical segment of advanced airway management, encompassing endotracheal tubes, tracheostomy tubes, and related devices used to secure the airway below the vocal cords. These devices are primarily utilized in intensive care units, operating rooms, emergency departments, and long-term ventilation settings for patients requiring mechanical ventilation, trauma management, or prolonged respiratory support. Market growth is driven by the rising incidence of respiratory failure, trauma cases, and chronic conditions such as COPD, along with increasing surgical volumes and expanding critical care admissions globally. Technological advancements, including antimicrobial-coated tubes, high-volume low-pressure cuffs, subglottic secretion drainage systems, and improved materials for enhanced biocompatibility, are improving patient safety and reducing complications such as ventilator-associated pneumonia. Additionally, the growing adoption of minimally traumatic insertion techniques, increasing demand for long-term home ventilation solutions, and expansion of critical care infrastructure in emerging economies are further supporting market expansion.

Overview of report findings

Market Growth

The infraglottic devices market is projected to grow from US$ 3,184.4 million in 2025 to US$ 4,977.4 million by 2033, registering a compound annual growth rate (CAGR) of 5.4% between 2026 and 2033.

The global infraglottic devices market is driven by the increasing prevalence of severe respiratory failure and the rising need for advanced airway support in critical care and surgical settings. Growing demand for secure airway access during long-duration ventilation is accelerating adoption. Expanding use in intensive care units and emergency medicine, along with continuous advancements in tracheal tube design and cuff technology, are further supporting sustained market growth.

Rising Prevalence of Airway Disorder

The increasing prevalence of airway and respiratory disorders is a major driver of the infraglottic devices market, particularly endotracheal tubes and tracheostomy systems used for secure airway access below the glottis. Chronic conditions such as chronic obstructive pulmonary disease (COPD), severe asthma exacerbations, neuromuscular disorders, and obstructive sleep apnea are contributing to a growing patient population requiring advanced airway intervention. Infraglottic devices are essential in managing airway obstruction, prolonged ventilation, and surgical anesthesia, especially in critically ill patients. Aging populations are significantly influencing demand, as elderly patients exhibit higher rates of respiratory insufficiency, reduced airway reflexes, and increased need for intensive care support. Lifestyle factors such as smoking, air pollution exposure, and rising obesity prevalence further exacerbate respiratory compromise, increasing the need for invasive airway stabilization. Advancements in diagnostic tools, including high-resolution imaging, bronchoscopy, and point-of-care respiratory monitoring, have improved early detection of airway abnormalities, enabling timely intervention with infraglottic devices. Physician expertise in advanced airway management has also improved due to enhanced critical care training and standardized intubation protocols. Ongoing innovation in cuff design, antimicrobial-coated tubes, and subglottic secretion drainage systems is improving patient safety and reducing ventilator-associated complications. These technological developments, combined with expanding ICU capabilities globally, are expected to drive sustained long-term adoption of infraglottic airway solutions across emergency and surgical care settings.

Increase in ICU Admissions and Critical Care Cases

The rising number of intensive care unit (ICU) admissions and critical care cases is a significant driver of the infraglottic devices market. Patients with severe respiratory failure, trauma, sepsis, neurological impairment, and post-surgical complications often require mechanical ventilation, making endotracheal intubation and tracheostomy essential for airway protection and oxygenation support. This has led to increased utilization of infraglottic airway devices in critical care environments. The growing preference for minimally invasive and lung-protective ventilation strategies has further strengthened demand. Modern infraglottic devices are designed to minimize tracheal injury, reduce airway resistance, and enable efficient long-term ventilation. Their use is particularly important in high-risk patients, including those with acute respiratory distress syndrome (ARDS), where precise airway control is critical for survival. Technological advancements such as high-volume low-pressure cuffs, antimicrobial materials, and subglottic secretion suction systems have significantly reduced complications like ventilator-associated pneumonia (VAP). These innovations improve patient outcomes and shorten ICU stays, supporting hospital efficiency and cost reduction. The expansion of critical care infrastructure in emerging economies across Asia-Pacific, Latin America, and the Middle East is further driving market growth. Increased ICU bed capacity, improved emergency response systems, and rising surgical volumes are collectively contributing to higher adoption of infraglottic airway devices. Enhanced clinical protocols and global critical care guidelines continue to reinforce their essential role in modern intensive care management.

Geographic Insights

North America leads the infraglottic devices market, primarily driven by its strong critical care and trauma management ecosystem where invasive airway access is frequently required. High rates of severe respiratory failure cases, major trauma incidents, and complex surgical procedures support consistent demand for tracheostomy tubes and related devices. The region has well-established ICU protocols that encourage early tracheostomy in long-term ventilated patients to reduce complications and hospital stay duration. Advanced hospital infrastructure, skilled intensivists, and rapid adoption of percutaneous tracheostomy techniques further strengthen usage. In addition, strong device innovation in cuff design, antimicrobial coatings, and portable tracheostomy care systems enhances clinical adoption across acute and post-acute care settings.

Europe holds a significant share due to its structured intensive care frameworks and strong emphasis on standardized tracheostomy care protocols across public hospitals. The region has high utilization in long-term ventilation cases, particularly among elderly patients and those with neurodegenerative disorders requiring extended respiratory support. European ICUs are known for early mobilization and decannulation protocols, which influence consistent use of infraglottic airway solutions. Strong nursing care systems and rehabilitation-focused healthcare models also support long-term tracheostomy management outside acute hospital settings. Additionally, collaborative clinical research across EU countries has contributed to refinements in tracheostomy timing, technique, and post-procedural care, reinforcing steady demand.

Asia Pacific is the fastest-growing region, supported by rapidly expanding ICU capacity and increasing burden of respiratory failure, stroke, and road traffic injuries requiring long-term ventilation support. Many emerging healthcare systems are shifting from prolonged endotracheal intubation toward tracheostomy-based ventilation strategies to improve patient outcomes and reduce ICU resource strain. Rising investments in critical care infrastructure, particularly in China and India, are expanding access to infraglottic airway procedures in tertiary hospitals. Growing training programs in intensive care medicine and increasing availability of cost-effective tracheostomy kits from domestic manufacturers are further accelerating adoption. The expansion of post-acute and home-based tracheostomy care services is also emerging as a key growth driver in the region.

Market Segmentation

• By product type, the infraglottic devices market is segmented into endotracheal tubes, tracheostomy tubes, and endobronchial tubes. The endotracheal tubes segment dominated the market in 2025. This dominance is driven by their widespread use as the standard method for securing the airway in surgical procedures, critical care settings, and emergency interventions, owing to their high reliability in maintaining ventilation and preventing aspiration.
• Based on product design, the infraglottic devices market is classified into cuffed devices and uncuffed devices. The cuffed devices segment dominated the market in 2025. This leadership is attributed to their superior ability to create a sealed airway, reduce the risk of aspiration, and ensure effective positive pressure ventilation, making them particularly suitable for anesthesia, intensive care, and emergency airway management.
• In terms of application, the infraglottic devices market is segmented into anesthesia, critical care, emergency medicine, and others. The anesthesia segment dominated the market in 2025. This is primarily due to the extensive use of endotracheal intubation during surgical procedures requiring general anesthesia, where secure airway control and controlled ventilation are essential for patient safety.
• By patient type, the infraglottic devices market is divided into adult and pediatric patients. The adult segment dominated the market in 2025. This dominance is driven by the higher volume of surgical procedures, greater incidence of respiratory and chronic diseases, and increased occurrence of trauma and emergency cases among the adult population requiring advanced airway management.
• By end user, the infraglottic devices market is categorized into hospitals, ambulatory surgical centers, emergency medical services, and others. The hospitals segment dominated the market in 2025. Hospitals remain the primary end users due to their advanced surgical infrastructure, availability of intensive care units, and presence of skilled healthcare professionals capable of performing complex airway management procedures across varied clinical settings.

Competitive Strategy & Development

Key Players: The infraglottic devices market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic
2. Teleflex Incorporated
3. ICU Medical, Inc.
4. Intersurgical Ltd
5. GPC Medical Ltd
6. Flexicare (Group) Limited
7. Romsons
8. Ambu A/S
9. Medline
10. AirLife

Trending Topics: Advanced cuffed endotracheal tubes (micro-cuff and high-volume low-pressure designs), antimicrobial and anti-fog coated endotracheal tubes, subglottic secretion drainage endotracheal tubes, reinforced and flexible endotracheal tubes for critical care, double-lumen endotracheal tubes for lung isolation, video-assisted endotracheal intubation systems, disposable endotracheal tubes for infection control, pediatric and neonatal endotracheal tubes, tracheostomy tubes (cuffed and uncuffed variants), percutaneous tracheostomy kits and systems

Global Headlines

• Medtronic recalled Shiley™ adult flexible tracheostomy tubes with TaperGuard cuff – In June 2025, Medtronic announced a Class I recall due to flange disconnection risk, potentially causing airway obstruction, respiratory failure, and need for emergency re-intubation in ICU patients.
• Teleflex/Arrow International recalled intra-aortic balloon catheter kits (adjacent infraglottic critical care devices) – In June 2024, Teleflex announced a recall due to manufacturing defects that may prevent full balloon inflation and compromise patient hemodynamic support in critical care.
• Medline Industries issued urgent recall of Sub-G Endotracheal Tubes with Subglottic Suctioning – In February 2024, Medline announced a Class I recall (FDA classification) due to risks of inflation tube detachment, cuff failure, airway obstruction, and potential hypoxemia during mechanical ventilation, impacting ICU and emergency intubated patients.

Conclusion

The global Infraglottic Devices market is experiencing steady expansion, driven by the increasing prevalence of chronic respiratory conditions, trauma cases, and a rising number of critical care and emergency interventions requiring advanced airway support. Growing adoption of endotracheal tubes, tracheostomy tubes, and related ventilation accessories is being reinforced by continuous product innovations focused on improved biocompatibility, reduced airway resistance, and enhanced patient comfort. North America and Europe remain established markets, supported by advanced intensive care infrastructure and well-defined clinical protocols, while Asia-Pacific is emerging as the fastest-growing region due to rising healthcare expenditure and expanding hospital networks. Latin America and the Middle East & Africa are witnessing gradual uptake, supported by improving critical care capabilities. Favorable clinical guidelines, increasing emphasis on long-term ventilation care, and strengthened regulatory standards are further supporting market growth.